Follow
Naohiro Uchio
Naohiro Uchio
Mitsui Memorial Hospital
Verified email at umin.ac.jp
Title
Cited by
Cited by
Year
Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy
M Kadoya, A Hida, M Hashimoto Maeda, K Taira, C Ikenaga, N Uchio, ...
Neurology: Neuroimmunology & Neuroinflammation 3 (6), e290, 2016
1002016
Gpr176 is a Gz-linked orphan G-protein-coupled receptor that sets the pace of circadian behaviour
M Doi, I Murai, S Kunisue, G Setsu, N Uchio, R Tanaka, S Kobayashi, ...
Nature communications 7 (1), 10583, 2016
672016
Inflammatory myopathy with myasthenia gravis: thymoma association and polymyositis pathology
N Uchio, K Taira, C Ikenaga, M Kadoya, A Unuma, K Yoshida, ...
Neurology: Neuroimmunology & Neuroinflammation 6 (2), e535, 2018
392018
Clinicopathologic features of myositis patients with CD8-MHC-1 complex pathology
C Ikenaga, A Kubota, M Kadoya, K Taira, N Uchio, A Hida, MH Maeda, ...
Neurology 89 (10), 1060-1068, 2017
312017
Identification and segmentation of myelinated nerve fibers in a cross-sectional optical microscopic image using a deep learning model
T Naito, Y Nagashima, K Taira, N Uchio, S Tsuji, J Shimizu
Journal of neuroscience methods 291, 141-149, 2017
252017
Granulomatous myositis induced by anti–PD-1 monoclonal antibodies
N Uchio, K Taira, C Ikenaga, A Unuma, M Kadoya, A Kubota, T Toda, ...
Neurology: Neuroimmunology & Neuroinflammation 5 (4), e464, 2018
172018
Circadian characteristics of mice depleted with GPR7
N Uchio, M Doi, M Matsuo, F Yamazaki, Y Mizoro, M Hondo, T Sakurai, ...
Biomedical Research 30 (6), 357-364, 2009
122009
Progressive supranuclear palsy with wall-eyed bilateral internuclear ophthalmoplegia syndrome: authors’ second case
H Matsumoto, T Inaba, T Kakumoto, R Miyano, N Uchio, Y Sakurai
Case Reports in Neurology 11 (2), 205-208, 2019
72019
Pembrolizumab on pre-existing inclusion body myositis: a case report
N Uchio, A Unuma, T Kakumoto, M Osaki, Y Zenke, K Sakuta, A Kubota, ...
BMC rheumatology 4, 1-4, 2020
42020
Endoplasmic reticulum stress caused by aggregate‐prone proteins containing homopolymeric amino acids
N Uchio, Y Oma, K Toriumi, N Sasagawa, I Tanida, E Fujita, Y Kouroku, ...
The FEBS Journal 274 (21), 5619-5627, 2007
42007
Myasthenia gravis with inflammatory myopathy without elevation of creatine kinase
T Kanbayashi, S Tanaka, Y Hatanaka, N Uchio, J Shimizu, M Sonoo
Neuromuscular Disorders 31 (6), 570-573, 2021
32021
Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy. Neurol Neuroimmunol Neuroinflamm 2016; 3: e290
M Kadoya, A Hida, M Hashimoto Maeda
3
Intravenous Immunoglobulin in the Treatment of Adalimumab-associated Optic Neuritis
N Uchio, D Yashita, A Hao, T Takahashi, H Matsumoto
Internal Medicine 61 (3), 429-432, 2022
22022
Symmetrical interhemispheric subdural hematoma
N Uchio, R Miyano, H Matsumoto
Cureus 13 (3), 2021
22021
A case of granulomatous myositis in a patient with rheumatoid arthritis receiving anti-TNF-α treatment
A Kawamura, Y Tsuchida, H Shoda, K Kubo, N Uchio, J Shimizu, K Fujio
Modern Rheumatology Case Reports 4 (1), 1-5, 2020
22020
Extremely long spinal cord infarction
D Yashita, A Hao, N Uchio, H Matsumoto
JMA journal 6 (3), 350-351, 2023
12023
Impact of The COVID-19 Pandemic on Neurology: Report from A General Hospital in Tokyo
H Matsumoto, A Hao, D Yashita, Y Sakurai, N Uchio
Journal of Health Science and Medical Research 40 (2), 203-214, 2022
12022
Alanine transaminase is predominantly increased in the active phase of anti-HMGCR myopathy
A Kubota, J Shimizu, A Unuma, M Maeda, Y Shirota, M Kadoya, N Uchio, ...
Neuromuscular Disorders 32 (1), 25-32, 2022
12022
Prominent Prolongation of Cortical Silent Period Induced by Transcranial Magnetic Stimulation in Creutzfeldt-Jakob Disease
H Matsumoto, N Uchio, A Hao, M Haga, C Abe, Y Sakamoto, Y Ugawa
Case Reports in Neurology 12 (3), 447-451, 2021
12021
Lhermitte's Sign in a Patient with Thoracic Myelitis
R Miyano, N Uchio, T Takahashi, H Matsumoto
Internal Medicine 59 (14), 1787-1788, 2020
12020
The system can't perform the operation now. Try again later.
Articles 1–20